As of January 5, 2026, Fujifilm Irvine Scientific Inc. has formally changed its legal name to Fujifilm Biosciences Inc. This rebranding signifies a strategic milestone in the company’s expansion within the global life sciences sector.
Rationale for the new identity The transition to Fujifilm Biosciences reflects the company’s evolution from a specialized cell culture media provider to a comprehensive solutions partner. The new name is designed to resonate with a broader scientific community, supporting every phase of the lifecycle—from initial discovery and development to full-scale commercialization.
Core product and service ecosystem Fujifilm Biosciences will continue to advance its extensive portfolio, which includes:
-
Cell culture media and feeds.
-
Specialty chemicals and high-purity reagents.
-
Single-use technologies.
-
Human-induced pluripotent stem cell (iPSC) capabilities.
Commitment to global innovation Leveraging a 55-year industry legacy, the company’s leadership emphasized that this rebranding is supported by ongoing investments in its global manufacturing network. The primary mission remains accelerating the development of transformative therapies to improve global patient outcomes through collaborative innovation with researchers and industry partners.